Results 241 to 250 of about 6,650,662 (298)
Some of the next articles are maybe not open access.

DxS Ltd

Pharmacogenomics, 2003
DxS is a pharmacogenomics business operating at the interface between genetic diagnostics and the pharmaceutical industry. The company strategy is to enable pharmacogenomics by the provision of genetic analysis services to the healthcare sector.
openaire   +2 more sources

Guna Fibres, Ltd.

Darden Business Publishing Cases, 2017
The chief executive of a small yarn-production company in India must resolve an unexpected cash shortage. The task for the student is to evaluate the causes of this shortage (using a completed “base-case” forecast given in the case) and assess the usefulness of various possible remedies suggested by managers.The company is unable to liquidate a ...
Michael J. Schill   +2 more
openaire   +1 more source

DxS Ltd

Pharmacogenomics, 2008
DxS is a personalized medicine company that meets the needs of the pharmaceutical industry for biomarkers and companion diagnostics to support the development and sales of cancer and other therapies. The company provides both biomarker products, which are used predominately during clinical trials, and companion diagnostics, which aid doctors in ...
openaire   +2 more sources

MediMedia International, Ltd

Darden Business Publishing Cases, 2008
In February 1991, the managers of this multinational specialty publishing company proposed to take the company private in a leveraged buyout (LBO). In addition to the ordinarily interesting features of the typical LBO, this transaction was the first to be denominated in European currency units (ECUs) and one of the few in which the managers provided ...
openaire   +1 more source

British Petroleum, Ltd.

Darden Business Publishing Cases, 2008
This case is one of a pair of cases used in a merger negotiation. It is designed to be used with “Amoco Corporation” (UVA-F-1262). One-half of the class prepares only the Amoco case, and one-half uses this case. BP and Amoco are considering a merger, and are in the process of negotiating a merger agreement.
Susan J. Chaplinsky   +2 more
openaire   +1 more source

GEOFABRICS LTD v FIBERWEB GEOSYNTHETICS LTD

Reports of Patent, Design and Trade Mark Cases, 2022
Abstract H1 Patents — Infringement — Geocomposites — Injunctions — Permanent injunctive relief granted at trial but stayed pending appeal — Appeal unsuccessful — New product not the subject of the infringement action — Pending DNI proceedings — Whether injunction should be stayed or modified in the ...
openaire   +1 more source

Elliott Products Ltd

1978
This case describes the history and justification of a capital investment project. It is typical of how many investment proposals evolve in organisations. Consequently it is more illuminating in terms of the strategic, control and organisational context of capital budgeting than of the techniques of appraisal per se.
Andrew M. McCosh, Michael J. Earl
openaire   +1 more source

Sengupta Fibres, Ltd.

Darden Business Publishing Cases, 2008
In January 1990, the chief executive of this small yarn-production company must resolve a surprising cash shortage. The tasks for the student are to evaluate the causes of this shortage (using a complete base case forecast given in the case) and then to assess the usefulness of various possible remedies suggested by company managers.
Robert F. Bruner, Thien Pham
openaire   +1 more source

77m LTD v ORDNANCE SURVEY LTD

Reports of Patent, Design and Trade Mark Cases, 2020
  H1 Database right – Infringement – Mapping – Geospatial coordinates – Address matching – Licensing agreements – Sub-licensing – Breach of contract – Construction – Scope of rights granted – Subsistence of database right – Verification of existing data – Extraction – Consultation – Re-utilisation – Defences – Authorised extraction ...
openaire   +1 more source

Voriconazole (Pfizer ltd).

IDrugs : the investigational drugs journal, 1999
Voriconazole is undergoing phase III trials by Pfizer as a potential treatment for resistant systemic aspergillosis, candidosis and other emerging fungal infections seen in immunocompromised patients [201603,320737]. The compound demonstrated efficacy in patients in whom amphotericin had failed to control infection [167646].
Verweij, P.E.   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy